Comparative Effectiveness Research (CER) is the new frontier in Rheumatoid Arthritis (RA). CER will play a key part in selecting the best treatment regimen for your patient. Do you know how it works? RAVE: ICE can help!

CER is changing clinical practice guidelines. It is already playing a role in determining which drugs are placed on formularies for treating RA. This webinar is designed to help you understand the importance of CER and how it will impact the treatment of patients with RA.

Rave: ICE is supported by an educational grant from Bristol-Myers Squibb, Inc.

GO TO RAVE:ICE PROGRAM

RAVE Mobile iOS and Android App


NEW RAVE MOBILE APP
RAVE Mobile is an educational app that provides interactive tools for you and your practice. This update to RAVE Mobile was developed as part of the RAVE: ICE and is now available on the #1 app for rheumatologists in the iTunes App Store.

Key new features include:

Ankylosing spondylitis diagnosis calculators: Ankylosing Spondylitis Disease Activity Score (ASDAS) and Bath Ankylosing Spondylitis Patient Global Score (BAS-G)

Ankylosing spondylitis disease activity scales: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI)

Classification Criteria for Psoriatic Arthritis (CASPAR)

Psoriatic arthritis disease activity scales::Psoriatic Arthritis Disease Activity Score (PASDAS) and Composite Psoriatic Disease Activity Index (CPDAI)

This update of the app is supported by an unrestricted educational grant from Novartis and SpARK (Novartis Aiming for Remission in Spondyloarthritis).

VIEW IN iTUNES

Jointly sponsored and presented by Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center, and DKBmed, LLC

Treat-To-Target

GO TO RAVE T2T PROGRAM